TCM
ENZ

Tang Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Tang Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,260,013
Closed -$1.6M – 139
2024
Q1 		$1.6M Sell
1,260,013
-439,987
-26% -$581K 0.17% 81
2023
Q4 		$2.36M Sell
1,700,000
-500,000
-23% -$663K 0.22% 86
2023
Q3 		$3.08M Sell
2,200,000
-100,000
-4% -$151K 0.43% 60
2023
Q2 		$4.23M Hold
2,300,000
– – 0.62% 46
2023
Q1 		$5.59M Buy
+2,300,000
New +$3.42M 0.83% 38

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Tang Capital Management's ENZ Position: Q2 2024 in Review

Tang Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2024, closing a stake of 1,260,013 shares — an estimated $1.6M sold.

Tang Capital Management first reported a position in ENZ in Q1 2023 and held it in 5 quarters. The position peaked at $5.59M in Q1 2023. 39 funds tracked by Wall St. Rank hold ENZ as of Q2 2024.

  • Tang Capital Management reported no remaining Enzo Biochem, Inc. position as of Q2 2024 after selling out during the quarter.
  • Tang Capital Management sold 1,260,013 Enzo Biochem, Inc. shares in Q2 2024, an estimated $1.6M.
  • Tang Capital Management first reported a position in Enzo Biochem, Inc. in Q1 2023 and held it in 5 quarters.
  • Tang Capital Management's Enzo Biochem, Inc. position peaked at $5.59M in Q1 2023.
  • 39 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2024.

Based on Tang Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.